{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:47:31Z","timestamp":1648752451191},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T00:00:00Z","timestamp":1187654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s11239-007-0085-x","type":"journal-article","created":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T12:57:03Z","timestamp":1187614623000},"page":"198-203","source":"Crossref","is-referenced-by-count":2,"title":["Effect of low and high dose melagatran and other antithrombotic drugs on platelet aggregation"],"prefix":"10.1007","volume":"25","author":[{"given":"Gerald","family":"Soslau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LaToya","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,21]]},"reference":[{"key":"85_CR1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semvascsurg.2005.05.004","volume":"18","author":"J Ansell","year":"2005","unstructured":"Ansell J (2005) Long-term anticoagulation: the prospects for alternatives to warfarin. Semin Vasc Surg 18:134\u2013138","journal-title":"Semin Vasc Surg"},{"key":"85_CR2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.166.8.853","volume":"166","author":"JD Douketis","year":"2006","unstructured":"Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halpern F, Horrow J (2006) Comparison of bleeding in patients with nonvascular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Arch Intern Med 166:853\u2013859","journal-title":"Arch Intern Med"},{"key":"85_CR3","doi-asserted-by":"crossref","first-page":"21173","DOI":"10.1074\/jbc.M008249200","volume":"276","author":"G Soslau","year":"2001","unstructured":"Soslau G, Class R, Morgan DA, Foster C, Lord St, Marchese P, Ruggeri ZM (2001) Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 276:21173\u201321183","journal-title":"J Biol Chem"},{"key":"85_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/0953710042000199848","volume":"15","author":"G Soslau","year":"2004","unstructured":"Soslau G, Goldenberg SJ, Class R, Jameson B (2004) Differential activation and inhibition of human platelet thrombin receptors by structurally distinct \u03b1-,\u03b2- and \u03b3-thrombin. Platelets 15:155\u2013166","journal-title":"Platelets"},{"key":"85_CR5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0037-1614245","volume":"79","author":"D Gustafsson","year":"1998","unstructured":"Gustafsson D, Antonsson T, Bylund R, Eriksson U, Gyzander E, Nilsson I, Egl M, Mattsson C, Deinum J, Pehrsson S, Karlsson E, Nilsson A, Sorensen H (1998) Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes. Thromb Haemost 79:110\u2013118","journal-title":"Thromb Haemost"},{"key":"85_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/vhrm.2006.2.1.49","volume":"2","author":"SJ Ho","year":"2006","unstructured":"Ho SJ, Brighton TA (2006) Ximelagatran: direct thrombin inhibitor. Vasc Health Risk Manage 2:49\u201358","journal-title":"Vasc Health Risk Manage"},{"key":"85_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.med.45.1.165","volume":"45","author":"PH Johnson","year":"1994","unstructured":"Johnson PH (1994) Hirudin: clinical potential of a thrombin inhibitor. Annu Rev Med 45:165\u2013177","journal-title":"Annu Rev Med"},{"key":"85_CR8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.thromres.2004.11.006","volume":"116","author":"WH Matthai Jr","year":"2005","unstructured":"Matthai WH Jr, Hursting MJ, Lewis BE, Kelton JG (2005) Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia. Thromb Res 116:121\u2013126","journal-title":"Thromb Res"},{"key":"85_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1358\/dot.2006.42.5.973580","volume":"42","author":"SA Mousa","year":"2006","unstructured":"Mousa SA (2006) Role of current and emerging antithrombotics in thrombosis and cancer. Drugs Today (Barc) 42:331\u2013350","journal-title":"Drugs Today (Barc)"},{"key":"85_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00001721-200302000-00007","volume":"14","author":"S Nylander","year":"2003","unstructured":"Nylander S, Mattsson C (2003) Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action. Blood Coagul Fibrinolysis 14:159\u2013167","journal-title":"Blood Coagul Fibrinolysis"},{"key":"85_CR11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMra044440","volume":"353","author":"M Nisio Di","year":"2005","unstructured":"Di Nisio M, Middeldorp S, B\u00fcller HR (2005) Direct thrombin inhibitors. N Engl J Med 353:1028\u20131040","journal-title":"N Engl J Med"},{"key":"85_CR12","first-page":"255a","volume":"100","author":"G Soslau","year":"2002","unstructured":"Soslau G, Goldenberg SJ, Class R (2002) Differential activation and inhibition of human platelet thrombin receptors by structurally distinct \u03b1-,\u03b2- and \u03b3-thrombin. Blood 100:255a","journal-title":"Blood"},{"key":"85_CR13","first-page":"255a","volume":"100","author":"G Soslau","year":"2002","unstructured":"Soslau G, Goldenberg SJ, Navas E, Mattsson C, Nylander S (2002) (Xi) Melagatran inhibition of alpha-thrombin GPlb and beta, gamma-thrombin-PAR-4 platelet aggregation pathways. Blood 100:255a","journal-title":"Blood"},{"key":"85_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0037-1614245","volume":"79","author":"D Gustafsson","year":"1998","unstructured":"Gustafsson D, Antonsson T, Bylund R, Eriksson U, Gyzander E, Nilsson I, Mattsson C, Deinum J, Pehrsson S, Karlsson O, Nilsson A, Sorensen H (1998) Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes. Thromb Haemost 79:110\u2013118","journal-title":"Thromb Haemost"},{"key":"85_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2004.07.001","volume":"115","author":"SC Carlsson","year":"2005","unstructured":"Carlsson SC, Mattsson C, Eriksson UG, Sarich TC, Wahlander K, Eliasson A, Karlson BW, Sheth SB, Held P (2005) A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays. Thromb Res 115:9\u201318","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-007-0085-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-007-0085-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-007-0085-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:01:35Z","timestamp":1559386895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-007-0085-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,21]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s11239-007-0085-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,21]]}}}